The fetal and adult lung have a constant level of collagen synthesis that represents 4-5% of the total amino acids incorporated into lung protein. Prior studies have demonstrated that this collagen is not homogeneous but rather is composed of at least two collagen types, I and II, each localized to specific lung structures. Although it is known that explants of rabit lung parenchyma and blood vessels synthesize type I collagen and that rabbit lung tracheobronchial tree synthesizes type II collagen, it has been suggested that other collagen types are present in lung. It is not known which cells are responsible for the synthesis of any lung collagen type. To approach the problem of additional lung collagen heterogeneity and the identification of the cells responsible for lung collagen synthesis, techniques were developed to examine collagen synthesized by lung cells in culture. 10-15% of the proteins synthesized by confluent cultures of rabbit lung cells and fetal human lung fibroblasts are collagen. Separation and purification of this collagen by ion-exchange chromatography and cyanogen bromide (CNBr) peptide mapping techniques indicate that collagen secreted by these cells is composed of two collagen types, I and III. The CNBr peptides of type I collagen secreted by these cells are identical to the CNBr peptides of type I collagen synthesized by lung parenchyma and blood vessels. The peptides of type III collagen secreted by these cells are identical to fetal skin type III collagen CNBr peptides. The existence of 40 cell types and the insolubility of lung collagen increase the complexity of identifying the types of collagen in lung and the cells responsible for the synthesis of each type. The techniques described here should eventually lead to a complete description of the synthesis and composition of lung collagen, thus providing a probe to understand the role of collagen in lung development and structure in health and disease.
A J Hance, K Bradley, R G Crystal
Usage data is cumulative from April 2023 through April 2024.
Usage | JCI | PMC |
---|---|---|
Text version | 88 | 0 |
48 | 9 | |
Scanned page | 112 | 0 |
Citation downloads | 14 | 0 |
Totals | 262 | 9 |
Total Views | 271 |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.